L. Julian Haywood, M. D. , Barry R. Davis, M. D. , Ph. D. , Linda B

Slides:

Advertisements

Similar presentations

1 ATRIAL FIBRILLATION AT BASELINE AND DURING FOLLOW-UP in The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial November 9, 2003.

Advertisements

Cardiovascular Outcomes in Hypertensives with CHD Randomized to Amlodipine versus Lisinopril in ALLHAT Frans Leenen MD, PhD, Chuke Nwachuku MA, MPH, Dr.

Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

Lipid abnormalities in foreign-born and US-born patients in a medical group Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,

Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery Emmanuel Akintoye, MD, MPH, Frank Sellke, MD,

Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: The Finland postpericardiotomy syndrome study Joonas Lehto, BM,

Aspirin Use Among U.S. Adults

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Volume 13, Issue 1, Pages (January 2016)

Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists Yu Jung Kim, MD, PhD, David Hui, MD,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Development of Reduced Kidney Function in Rheumatoid Arthritis

Management of pleural space infections: A population-based analysis

Volume 8, Issue 8, Pages (August 2011)

Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial Niv Ad, MD, Sari D. Holmes,

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Trend in Mortality after Stroke with Atrial Fibrillation

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials David Moher, MSc, Kenneth F Schulz,

Osteoporotic Fractures and Heart Failure in the Community

Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis Dharam J. Kumbhani, MD, SM, MRCP, Ph. Gabriel.

Historical perspectives of The American Association for Thoracic Surgery: Julian Johnson (1906–1987) J. William Gaynor, MD The Journal of Thoracic and.

Lifetime Risk of Venous Thromboembolism in Two Cohort Studies

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

Standard versus bicaval techniques for orthotopic heart transplantation: An analysis of the United Network for Organ Sharing database Ryan R. Davies,

William M. DeCampli, MD, PhD

A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy James E. Tisdale, PharmD, Heather.

Marye J. Gleva, MD, Charles B. Huddleston, MD

Timeliness Across the Continuum of Care in Veterans with Lung Cancer

Perioperative atrial tachycardia is associated with increased mortality in infants undergoing cardiac surgery Pirouz Shamszad, MD, Antonio G. Cabrera,

David L. S. Morales, MD, William J. Dreyer, MD, Susan W

Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial Keith Norris, MD, Jacque Bourgoigne, MD, Jennifer.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Quality of life outcomes are equivalent after lobectomy in the elderly

Competing risks need to be considered in survival analysis models for cardiovascular outcomes Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

Post-Heart Failure Mortality

Volume 14, Issue 12, Pages (December 2017)

Support Your Specialty

Fixing the supply problem

Military surgeons just want to have fun

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

M. Alan Brookhart, PhD, Jerry Avorn, MD, Jeffrey N

Left atrial pressure measurement in a rat is currently impossible due to size limitations of balloon occlusion catheter Filip Konecny, MSc, DVM, PhD

A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North.

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH

PICC-associated Bloodstream Infections: Prevalence, Patterns, and Predictors Vineet Chopra, MD, MSc, David Ratz, MS, Latoya Kuhn, MPH, Tracy Lopus, RN,

Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients Nicolas Amabile, MD,

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The future of cardiac surgery training: A survival guide

Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD, Charles E.

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Syndecan-1: A Quantitative Marker for the Endotheliopathy of Trauma

Why arch curvature affects arch resistance

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Did you like Terminator 3 better than Terminator 2

Case-finding for depression in primary care: a randomized trial∗ ∗

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non- small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Management of Atrial Fibrillation by Canadian Electrophysiologists After Early Termination of the PALLAS Study Kiarash Mohajer, BSc, Ben Fregeau, BSc,

Presentation transcript:

Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT L. Julian Haywood, M.D., Barry R. Davis, M.D., Ph.D., Linda B. Piller, M.D., M.P.H., William C. Cushman, M.D., Jeffrey A. Cutler, M.D., M.P.H., Charles E. Ford, Ph.D., Lara M. Simpson, Ph.D., Alokananda Ghosh, M.D., M.S., Elsayed Z. Soliman, M.D., M.Sc., M.S., Jackson T. Wright, M.D., Ph.D. Journal of the National Medical Association Volume 109, Issue 3, Pages 172-181 (September 2017) DOI: 10.1016/j.jnma.2017.02.005 Copyright © 2017 National Medical Association Terms and Conditions

Figure 1 Consort diagrams. Journal of the National Medical Association 2017 109, 172-181DOI: (10.1016/j.jnma.2017.02.005) Copyright © 2017 National Medical Association Terms and Conditions

Figure 2 Kaplan–Meier curves of cumulative incidence of all-cause mortality, cardiovascular death, and non-cardiovascular death for cases with baseline atrial fibrillation/atrial flutter or in-trial atrial fibrillation/atrial flutter, for all chlorthalidone, amlodipine, and lisinopril groups. Journal of the National Medical Association 2017 109, 172-181DOI: (10.1016/j.jnma.2017.02.005) Copyright © 2017 National Medical Association Terms and Conditions

Figure 3 Kaplan–Meier curves of cumulative incidence of all cause-mortality, cardiovascular death, and non-cardiovascular death for cases with either baseline atrial fibrillation/atrial flutter or incident baseline atrial fibrillation/atrial flutter, for the pravastatin and usual care groups. Journal of the National Medical Association 2017 109, 172-181DOI: (10.1016/j.jnma.2017.02.005) Copyright © 2017 National Medical Association Terms and Conditions